Atossa Therapeutics
ATOS
#10601
Rank
NZ$41.15 M
Marketcap
NZ$4.13
Share price
1.26%
Change (1 day)
211.80%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -NZ$64.37 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$59.28 Million a decrease over its 2024 earnings that were of -NZ$43.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$64.37 Million8.58%
2025 -NZ$59.28 Million36.33%
2024 -NZ$43.49 Million-15.25%
2023 -NZ$51.31 Million11.62%
2022 -NZ$45.97 Million30.84%
2021 -NZ$35.14 Million15.58%
2020 -NZ$30.4 Million3.41%
2019 -NZ$29.4 Million51.16%
2018 -NZ$19.45 Million40.41%
2017 -NZ$13.85 Million27.54%
2016 -NZ$10.86 Million-47.49%
2015 -NZ$20.68 Million-17.25%
2014 -NZ$25 Million35.91%
2013 -NZ$18.39 Million112.3%
2012 -NZ$8.67 Million46.53%
2011 -NZ$5.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.29 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.34 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.34 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$71.06 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$0.17 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$13.37 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA